Skip Navigation LinksIntegrated Review Groups > AIDS and Related Research IRG [AARR] > AIDS Discovery and Development of Therapeutics Study Section [ADDT]

AIDS Discovery and Development of Therapeutics Study Section [ADDT]

The AIDS Discovery and Development of Therapeutics [ADDT] Study Section reviews applications on the discovery, design, and evaluation of therapeutics for HIV and AIDS associated infections.  Proposed agents that inhibit the viral lifecycle and AIDS related diseases may include natural and synthetic products, gene-based strategies, and microbicides.

Rosters

Topics

  • Pre-clinical development of drugs, formulations, and delivery vehicles for HIV/AIDS therapy.
  • Identification and characterization of natural products for prevention or therapy of HIV/AIDS.
  • Mechanisms of drug action and viral drug resistance.
  • Development of targeted screens for new inhibitors of HIV/AIDS.
  • Discovery and development of microbicides to prevent HIV transmission.
  • Pharmacology of drugs and formulations for HIV/AIDS.
  • Design and development of gene-based therapies and vectors for HIV/AIDS.
  • Computational modeling and structure-assisted design of anti-HIV/AIDS agents.
  • Animal and tissue models for assessing delivery and efficacy of anti HIV/AIDS therapies.

Closely Related